Vieworks (KOSDAQ 100120) 2026 stock outlook. A deep qualitative look at its digital X-ray flat-panel detector OEM export model, installed-base recurring revenue, competition with Varex and Trixell, industrial-camera diversification, plus won-dollar FX and Chinese price-competition risk for foreign investors.
Nano-X Imaging (NNOX) 2026 stock analysis: cold-cathode Nanox.ARC digital tomosynthesis, pay-per-scan imaging-as-a-service model, Nanox.AI, FDA and deployment execution risk, past short-seller controversy, cash burn, and the traits of a high-volatility no-dividend small cap.
Lunit (KRX 328130) 2026 stock outlook. A qualitative deep dive into Lunit INSIGHT for AI-assisted cancer detection in chest X-ray and mammography, Lunit SCOPE for pathology biomarkers and companion diagnostics, the Volpara acquisition opening the US breast health market, and global pharma partnerships. We weigh the path to profitability against valuation and FDA regulatory risk for this loss-making growth stock.